×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
After Almost 4 Years, FDA Says Mesoblast Phase 3 Therapy Data Can Support Resubmission For Serious ...
Yahoo Finance
Monday, the FDA informed Mesoblast Limited (NASDAQ:MESO) that following additional consideration, the available clinical data from its Phase...
1 month ago
Mesoblast eyes accelerated approval filing for heart failure cell therapy
Pharmaceutical Technology
Mesoblast eyes accelerated approval filing for heart failure cell therapy. The race for the first FDA-approved cell therapy for patients with...
2 months ago
Mesoblast Shares Jump After FDA Nod for Submission of Remestemcel-L Application
Morningstar
Mesoblast's American depositary receipts surged after the company got the go-ahead from regulators to submit a biologics license application for...
1 month ago
Mesoblast enters collaboration for SR-aGVHD trial after FDA rejections
Clinical Trials Arena
Mesoblast resubmitted the BLA for Ryoncil in January 2023, with additional data that addressed a complete response letter (CRL) issued by the...
5 months ago
Mesoblast Limited (ASX:MSB) Insider Acquires A$151201.91 in Stock
Defense World
Mesoblast Limited (ASX:MSB – Get Free Report) insider Eric Rose bought 19,734 shares of the business's stock in a transaction on Wednesday,...
4 days ago
Mesoblast (NASDAQ:MESO) Shares Gap Down to $7.36
MarketBeat
Mesoblast Limited (NASDAQ:MESO - Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $7.36,...
2 days ago
Degenerative Disc Disease Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key ...
Barchart.com
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Degenerative Disc Disease pipeline constitutes 15+ key...
1 day ago
Mesoblast Director Increases Share Holdings - TipRanks.com
Tipranks
Mesoblast Limited (AU:MSB) has released an update. Mesoblast Limited has announced an update on its Director Dr. Eric Rose's interests, revealing that he...
6 days ago
Mesoblast Sees Path Forward for Twice-Rejected Cell Therapy After FDA Meeting
BioSpace
Following a Type A meeting with the FDA, Mesoblast claims it has a better understanding of what the regulator needs in order to consider...
7 months ago
Mesoblast Announces Appointment Of New Board Chair
Mirage News
Mesoblast (ASX:MSB) has announced that Joseph Swedish has chosen to step down as chair and will remain on the board until completion of his...
2 weeks ago